Fingerprint
Dive into the research topics of 'Twice-daily telaprevir for posttransplant genotype 1 hepatitis C virus: A prospective safety, efficacy, and pharmacokinetics study'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Twice-daily telaprevir for posttransplant genotype 1 hepatitis C virus: A prospective safety, efficacy, and pharmacokinetics study
Raymond A. Rubin, Mark W. Russo, Kimberly A. Brown, Robert J. Fontana, Josh Levitsky, Hugo Vargas, Eric M. Yoshida, Robert S. Brown
Research output: Contribution to journal › Article › peer-review